In this paper we explore the rise of ‘the breast cancer gene’ as a field of medical, cultural and personal knowledge. We address its significance in the Norwegian public health care system in relation to so-called biological citizenship in this particular national context. One of our main findings is that, despite its claims as a measure for health and disease prevention, gaining access to medical knowledge of BRCA 1/2 breast cancer gene mutations can also produce severe instability in the individuals and families affected. That is, although gene testing provides modern subjects with an opportunity to foresee their biological destiny and thereby become patients in waiting, it undoubtedly also comes with difficult existential dilemmas and ch...
This is a response to a short communication on our research presented in Solbrække et al. (Med Healt...
Background Females with BRCA 1/2 gene mutations have increased lifetime risk of breast and ovarian c...
In the human genome, BRCA1 and BRCA2 (for BReast CAncer 1 and 2) genes encode for proteins involved ...
This is a post-peer-review, pre-copyedit version of an article published in "Medicine, Health Care a...
Background: In South-Eastern Norway, genetic testing for BRCA1 and BRCA2 is offered to breast cancer...
The aim of this PhD project was to evaluate alternative procedures for genetic testing and counselli...
AbstractNowadays, the major tasks of the increasing number of family cancer clinics are to provide g...
Background: During the past two decades there has been an increasingly focus on cancer risk reductio...
Studies have shown that a significant number of eligible breast cancer patients are not offered gene...
This qualitative study explored the experiences of Norwegian men after being identified as BRCA 1/2 ...
The 21st century is recognized as the age of genetics due to significant discoveries that have revo...
In this era of personalisation a patient’s molecular profile plays an increasingly central role in d...
Breast cancer accounts for one third of all female cancer cases worldwide. A hereditary component ac...
Women who inherit the BRCA1/2 gene have up to an 85% lifetime chance of developing breast cancer and...
The aim of this exploratory study is to gain an understanding of lay people’s knowledge and understa...
This is a response to a short communication on our research presented in Solbrække et al. (Med Healt...
Background Females with BRCA 1/2 gene mutations have increased lifetime risk of breast and ovarian c...
In the human genome, BRCA1 and BRCA2 (for BReast CAncer 1 and 2) genes encode for proteins involved ...
This is a post-peer-review, pre-copyedit version of an article published in "Medicine, Health Care a...
Background: In South-Eastern Norway, genetic testing for BRCA1 and BRCA2 is offered to breast cancer...
The aim of this PhD project was to evaluate alternative procedures for genetic testing and counselli...
AbstractNowadays, the major tasks of the increasing number of family cancer clinics are to provide g...
Background: During the past two decades there has been an increasingly focus on cancer risk reductio...
Studies have shown that a significant number of eligible breast cancer patients are not offered gene...
This qualitative study explored the experiences of Norwegian men after being identified as BRCA 1/2 ...
The 21st century is recognized as the age of genetics due to significant discoveries that have revo...
In this era of personalisation a patient’s molecular profile plays an increasingly central role in d...
Breast cancer accounts for one third of all female cancer cases worldwide. A hereditary component ac...
Women who inherit the BRCA1/2 gene have up to an 85% lifetime chance of developing breast cancer and...
The aim of this exploratory study is to gain an understanding of lay people’s knowledge and understa...
This is a response to a short communication on our research presented in Solbrække et al. (Med Healt...
Background Females with BRCA 1/2 gene mutations have increased lifetime risk of breast and ovarian c...
In the human genome, BRCA1 and BRCA2 (for BReast CAncer 1 and 2) genes encode for proteins involved ...